AbbVie defeats Dutch antitrust claim over drug pricing
MLex Summary: AbbVie has seen a court in Amsterdam dismiss as inadmissible an excessive pricing lawsuit against it over the blockbuster drug Humira. The Pharmaceutical Accountability Foundation had brought the claim,...To view the full article, register now.
Already a subscriber? Click here to view full article